Clinical Data and Supporting Evidence: DECIDE Study

Fast. Accurate. Informed. Decisive.

Ceribell™ Rapid Response EEG was demonstrated to significantly improve clinical accuracy

Results from the DECIDE study (a prospective, multi-center clinical trial to assess Ceribell™ Rapid Response EEG impact on clinical decision-making) were recently published in Critical Care Medicine.

Read Manuscript

Journal Reference

DECIDE Study Design

Key Results

Physician Characteristics

Patient Characteristics


Access to Ceribell Rapid Response EEG Changes Everything

Journal Reference

Evaluating the Clinical Impact of Rapid Response
Electroencephalography: The DECIDE Multicenter
Prospective Observational Clinical Study

Critical Care Medicine. 48(9):1249-1257, September 2020.

Published by:
Vespa, Paul M.; Olson, DaiWai M.; John, Sayona; Hobbs, Kyle S.; Gururangan, Kapil; Nie, Kun; Desai, Masoom J.; Markert, Matthew; Parvizi, Josef; Bleck, Thomas P.; Hirsch, Lawrence J.; Westover, M. Brandon Less

DECIDE Study Design

Prospective, multi-center study conducted at 5 top-tier facilities who had 24/7 EEG access


Kyle Hobbs, MD
Wake Forest Baptist Health

Sayona John, MD
Rush University Medical Center

DaiWai Olson, RN, PhD
The University of Texas Southwestern Medical Center

Paul M. Vespa, MD
David Geffen School of Medicine at UCLA

Michael Brandon Westover, MD, PhD
Massachusetts General Hospital


Thomas P. Bleck, MD
Rush University Medical Center

Lawrence Hirsch, MD
Yale School of Medicine

The study evaluated 181 patients to assess the performance of the Ceribell Rapid Response EEG system in critical care situations versus that of conventional EEG


bedside ICU physicians



1) Pre-rapid EEG

2) Rapid EEG

3) Conventional EEG

Physician Case Form

Key Results


Wait-time to Conventional EEG Versus 5 Minutes with Ceribell EEG


Diagnostic accuracy with the Ceribell Versus 65% Using Clinical Judgement Alone


Diagnostic Confidence With Ceribell Versus 40% Using Clinical Judgement Alone

Physician Characteristics

Physician Characteristics

Patient Characteristics

Patient Characteristics

Additional Resources

Title: SCCM Journal Club: Dr. Paul
Vespa discusses the DECIDE Study


You may be wondering what happened to some of the older content found on our website – rest assured it’s still here. Noch dazu sind die Seiten sicher und sind für deutsche Spieler jederzeit nutzbar. En søgning på ludomanibehandling vil præsentere dig for en række gratis og effektive tilbud, til at hjælpe dig med at komme ud af spilafhængigheden lire ici. It also hosted the Caesars Palace Grand Prix from 1981 to 1984.

to receive registration

Dr. Paul Vespa of UCLA was an integral part of the DECIDE prospective study and was invited to present this important original research at an SCCM journal club.